Omicron BA.1 and BA.2 Neutralizing Activity Following Pre-Exposure Prophylaxis with Tixagevimab plus Cilgavimab in Vaccinated Solid Organ Transplant RecipientsAndrew H. Karaba, William A. Werbel, Amy Chang et al.|medRxiv|2022Cited by 21
Neutralizing activity and 3-month durability of tixagevimab and cilgavimab prophylaxis against Omicron sublineages in transplant recipientsAndrew H. Karaba, William A. Werbel, Jake D. Kim et al.|American Journal of Transplantation|2023Cited by 12
Letter to the editor: “hook” (prozone) effect in sars‐cov‐2 anti‐spike binding antibody levels following vaccination, infection, or monoclonal antibody in solid organ transplant recipientsAura T. Abedon, William A. Werbel, Teresa Po‐Yu Chiang et al.|Clinical Transplantation|2023Cited by 1